AAV9 Antibody |
|
MBS5310995-005mg |
MyBiosource |
0.05mg |
EUR 1455 |
Human IgG antibody Laboratories manufactures the progen aav9 elisa reagents distributed by Genprice. The Progen Aav9 Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Progen Inc.. Other Progen products are available in stock. Specificity: Progen Category: Aav9 Group: Elisa
Anti-AAV9 Antibody ELISA Kit |
|
ACROBIOSYSTEMS |
96tests |
EUR 1100.9 |
|
|
|
Description: Adeno-associated virus (AAV) has become one of the most important gene vectors in the field of gene therapy due to its long-term expression, low toxicity, low immunogenicity, and high tissue specificity.Most successful AAV gene therapies for preclinical and clinical studies are limited to natural serotypes, but the presence of neutralizing antibodies against AAV remains a significant barrier to systemic delivery. |
AAV9 Titration ELISA Kit |
|
Creative Diagnostics |
96T |
EUR 624 |
|
Description: cell culture supernatants, purified virus preparations |
Rat AAV9 ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Rat AAV9 ELISA Kit |
|
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Mouse monoclonal AAV9 antibody |
|
MyBiosource |
0.05mg |
EUR 1455 |
Elisa information
Human Adeno-Associated Virus 9 (AAV9) ELISA Kit |
|
abx050303-50g |
Abbexa |
50 µg |
Ask for price |
AAV9 Luciferase-eGFP |
|
78468 |
BPS Bioscience |
50 µl x 2 |
EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making it a desirable candidate for therapeutic applications._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and enhanced Green Fluorescent Protein (eGFP) genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript and expression of luciferase and eGFP as two separate proteins. |
AAV9 Luciferase-mCherry |
|
78477 |
BPS Bioscience |
50 µl x 2 |
EUR 545 |
|
Description: Adeno-Associated Virus serotype 9 (AAV9) is one of the most promising serotypes for gene therapy applications. AAV9 transduces a wide range of tissue types, including cardiac and skeletal muscle, liver, pancreas, and eye tissue. AAV8 and AAV9 have recently been used to correct disease-causing mutations and improve muscle function in mouse models of Duchenne muscular dystrophy. AAV9 has significantly lower seroprevalence in the human population than other AAV serotypes, making AAV9 a desirable candidate for therapeutic applications._x000D_These AAV particles constitutively express the firefly (Photinus pyralis) luciferase and mCherry genes connected via a T2A linker, under the control of a CMV promoter. The T2A self-cleaving peptide (derived from Thosea asigna virus 2A) leads to the efficient cleavage of the transcript and expression of luciferase and mCherry as two separate proteins. |
Mouse monoclonal AAV9 antibody |
|
MBS5316552-005mg |
MyBiosource |
0.05mg |
EUR 1455 |
Mouse monoclonal AAV9 antibody |
|
MBS5316552-5x005mg |
MyBiosource |
5x0.05mg |
EUR 6385 |
saCas9 Nuclease AAV Virus (AAV9) |
|
K216 |
ABM |
2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml |
EUR 375 |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
Adeno-Associated Virus 9 / AAV9 (intact particle) mouse monoclonal antibody, clone ADK9, Supernatant |
|
AM32480SU-N |
Origene Technologies GmbH |
5 ml |
Ask for price |
Anti-AAV9 Antibody ELISA Kit |
|
PAV-A009 |
ACROBIOSYSTEMS |
96tests |
EUR 1100.9 |
|
|
|
Description: Adeno-associated virus (AAV) has become one of the most important gene vectors in the field of gene therapy due to its long-term expression, low toxicity, low immunogenicity, and high tissue specificity.Most successful AAV gene therapies for preclinical and clinical studies are limited to natural serotypes, but the presence of neutralizing antibodies against AAV remains a significant barrier to systemic delivery. |
AAV5 ELISA Kit |
|
MBS539704-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
AAV1 ELISA Kit |
|
MBS539706-5x96Tests |
MyBiosource |
5x96Tests |
EUR 12990 |
AAV1 ELISA Kit |
|
MBS539706-96Tests |
MyBiosource |
96Tests |
EUR 2785 |
Dog Myeloid Progenitor Inhibitory Factor 1 ELISA kit |
|
E08M0335-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Canine Myeloid Progenitor Inhibitory Factor 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Myeloid Progenitor Inhibitory Factor 1 ELISA kit |
|
E08M0335-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Canine Myeloid Progenitor Inhibitory Factor 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |